High prevalence of autoantibodies among Danish centenarians

Clinical and Experimental Immunology

Volumn 138, Issue 1, 2004, Pages 158-163

  Andersen Ranberg, Karen ^a,b   Hoier Madsen M ^c   Wiik, A ^c   Jeune, B ^b   Hegedus L ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Autoantibodies; Autoimmunity; Centenarians; Comorbidity; Immunosenescence

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; HISTONE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY; MYELOBLASTIN; MYELOPEROXIDASE; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; NON ORGAN SPECIFIC ANTIBODY; ORGAN SPECIFIC ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PARIETAL CELL ANTIBODY; PROTEINASE 3 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR; RHEUMATOID FACTOR ANTIBODY; RO ANTIBODY; SINGLE STRANDED DNA BINDING PROTEIN; SINGLE STRANDED DNA BINDING PROTEIN ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; UNCLASSIFIED DRUG;

AGED; AGING; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CENTENARIAN; COMORBIDITY; DAILY LIFE ACTIVITY; DENMARK; DISABILITY; FEMALE; HUMAN; KATZ INDEX; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POPULATION RESEARCH; PRIORITY JOURNAL; SEROPREVALENCE;

AGED; AGED, 80 AND OVER; AGING; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COMORBIDITY; DENMARK; DISABILITY EVALUATION; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PARIETAL CELLS, GASTRIC; POPULATION SURVEILLANCE; PREVALENCE;

EID: 4644334096     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02575.x     Document Type: Article

References (38)

1. Wick G, Grubeck-Loebenstein B. Primary and secondary alterations of immune reactivity in the elderly: Impact of dietary factors and disease. Immunol Rev 1997; 160:171-84.
2. Makinodan T, Kay MMB. Age influence on the immune system. Adv Immunol 1980; 29:287-330.
3. Tomer Y, Shoenfeld Y. Ageing and autoantibodies. Autoimmunity 1988; 1:141-9.
4. Hijmans W, Radl J, Bottazzo GF et al. Autoantibodies in highly aged humans. Mech Ageing Dev 1984; 26:83-9.
5. Mariotti S, Sansoni P, Barbesino G et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 1992; 339:1506-8.
6. Mariotti S, Chiovato L, Franceschi C et al. Thyroid autoimmunity and aging. Exp Gerontol 1998; 33:535-41.
7. Franceschi C, Monti D, Sansoni P et al. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995; 16:12-6.
8. Francesci C, Monti D, Barbieri D et al. Successful immunosenescence and the remodelling of immune responses with ageing. Nephrol Dial Transplant 1996; 11:18-25.
9. Magri F, Muzzoni B, Cravello L et al. Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. Metabolism 2002; 51:105-9.
10. Mariotti S, Barbesino G, Chiovato L et al. Circulating thyroid autoantibodies in a sample of Italian octo-nonagenarians: Relationship to age, sex, disability, and lipid profile. Ageing (Milano) 1999; 11:362-6.
11. Andersen-Ranberg K, Schroll M, Jeune B. Healthy centenarians do not exist, - but autonomous centenarians do: a population-based study of morbidity among Danish centenarians. J Am Geriatr Soc 2001; 49:900-8.
12. Andersen-Ranberg K, Vasegaard L, Jeune B. Dementia in centenarians. J Gerontol Psy Sci 2001; 56B:P152-P159.
13. Katz S, Ford AB, Moskowitz RW et al. Studies of illness in the aged. The Katz Index of ADL, a standardized measure of biological and psychosocial function. J Am Med Assoc 1963; 185:914-9.
14. Høier-Madsen M, Nielsen LP, Møller S. Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA). Ugeskr Laeger 1986; 148:2018-21 (In Danish).
15. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97 (Suppl. 6):12-3.
16. Wiik A. Antineutrophil cytoplasmic antibodies (ANCA's) and ANCA testing. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of Clinical Laboratory Immunology, 6th edn. Washington DC: ASM Press, 2002:981-6.
17. Mouritsen S, Høier-Madsen M, Wiik A et al. The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus. Clin Exp Immunol 1989; 76:178-83.
18. Erickson EN, Najmey SS, Keil LB et al. Reference calibrators for investigators. Clin Chem 1996; 42:1116-7.
19. 2- glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia. Lupus 2001; 10:533-8.
20. Mouritsen S, Høier-Madsen M, Demant EJF et al. Enzyme-linked immunosorbent assay for determination of anti-mitochondrial antibodies. APMIS Section C 1985; 93:205-10.
21. Høier-Madsen M, Andersen M. Microhaemagglutination test for detection of antibodies to 'extractable nuclear antigen' (ENA). Comparative investigations in different groups of patients for ANA, DNA- and ENA-antibodies. Ugeskr Laeger 1980; 142:2627-30. (In Danish).
22. Andersen-Ranberg K, Jeune B, Høier-Madsen M et al. Thyroid function, morphology and prevalence of thyroid disease in a population-based study of Danish centenarians. J Am Geriatr Soc 1999; 47:1238-43.
23. Svee KH, Veit BC. Age-related antinuclear factor, immunologic characteristics and associated clinical aspects. Arthritis Rheum 1967; 10:509-16.
24. Willkens RF, Whitaker RR, Andersen RV et al. Significance of antinuclear factors in older persons. Ann Rheum Dis 1967; 26:306-10.
25. Wiik A, Jensen E, Friis J. Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis 1974; 33:515-22.
26. Manousakis MN, Tzioufas AG, Silis MP et al. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69:557-65.
27. Candore G, Di Lorenzo G, Mansueto P et al. Prevalence of organs-specific and non organ-specific autoantibodies in healthy centenarians. Mech Ageing Dev 1997; 94:183-90.
28. Tan EM, Feltkamp TEW, Smolen JS et al. Range of antinuclear antibodies in 'healthy' individuals. Arthrtis Rheum 1997; 40:1602-11.
29. Brimnes J, Halberg P, Wiik A et al. Specificities of antineutrophil autoantibodies in patients with rheumatoid arthritis. Clin Exp Immunol 1997; 110:250-6.
30. Brimnes J, Nielsen OH, Wiik A et al. Molecular targets of autoantibodies in patients with ulcerative colitis. Dig Dis Sci 1999; 44:415-23.
31. Talor E, Rose NR. Hypothesis. the aging paradox and autoimmune disease. Autoimmunity 1991; 8:245-9.
32. Roberts-Thompson IC, Whittingham S, Young-Chayud V et al. Ageing, immune response and mortality. Lancet 1974; 2:368-70.
33. Potocka-Plazak K, Pituch-Noworolska A, Kocembra J. Prevalence of autoantibodies in the very elderly: association with symptoms of ischemic heart disease. Ageing (Milano) 1995; 7:218-20.
34. Reinberg-Laiko L, Louhija J, Rautelin H et al. Helicobacter antibodies in Finnish centenarians. J Gerontol Med Sci 1999; 54A:M400-M403.
35. Lighthart GJ, Corberand JX, Fournier C et al. Admission criteria for immuno-gerontological studies in man: The SENIEUR protocol. Mech Ageing Dev 1984; 28:47-55.
36. Jeune B. Living longer - but better? Aging Clin Exp Res 2002; 14:72-93.
37. Fried L, Tangen C, Walston J et al. Frailty in older adults: Evidence for a phenotype. J Gerontol Med Sci 2001; 56A:M146-M156.
38. Morley JE, Perry HM III, Miller DK. Something about frailty (Editorial). J Gerontol Med Sci 2002; 57A:M698-M704.